RESUMEN

La Sociedad Colombiana de Urología (SCU) decidió realizar la adaptación de la guía de manejo de HPB.[1] [2] Las recomendaciones finales de esta guía se basan en una revisión sistemática de la literatura hasta 2020. Esta guía ofrece evidencia práctica en la evaluación y el tratamiento de hombres mayores de 40 años que se presentan con síntomas del tracto urinario inferior (SUOB).

The Colombian Society of Urology (SCU) decided to adapt the BPH management guideline.[1] [2] The final recommendations of this guideline are based on a systematic review of the literature until 2020. This guideline provides practical evidence in the evaluation and management of men over 40 years of age presenting with lower urinary tract symptoms (LUTS).

Asunto(s)

RESUMEN

Introducción El cáncer de vejiga es el noveno cáncer más frecuente para ambos sexos con una incidencia en ascenso. Habiendo una aparente relación entre el desarrollo de los países y la epidemiología del cáncer; el objetivo de este artículo es observar la epidemiología del cáncer de vejiga en nuestro medio respecto a otros países y describir los posibles factores asociados. Métodos Se realizó una revisión de la literatura en cuatro bases de datos: Medline, Embase, Cochrane database y Lilacs. Se incluyeron estudios de incidencia, prevalencia, mortalidad, sobrevida y carga de enfermedad, publicados en los últimos 5 años. Resultados Se encontraron 7806 referencias que fueron discriminadas por título y resumen, incluyendo al final 44 referencias en texto completo. Se observaron tasas de incidencia y mortalidad diferentes, siendo las más altas las encontradas en Europa principalmente en la República Checa seguido de Norte América. En Colombia, la incidencia general es de 6,8/100.000 en hombres y 2,1/100.000 en mujeres entre 2003 y 2007, encontrando cifras bajas en departamentos como la Guajira. Conclusiones Se ha observado un ascenso en la incidencia y mortalidad del cáncer de vejiga a nivel global. Parece haber una asociación con el tabaquismo y la dieta, así como con el Índice de Desarrollo Humano. Existe una escasa información en Latino América. En Colombia, observando los datos de algunos departamentos y la distribución de especialistas por regiones, se puede suponer un sub-registro haciendo necesario mejorar los sistemas de vigilancia, así como las políticas de salud para el diagnóstico e intervención temprana del cáncer.

Introduction Bladder cancer is the ninth most common cancer for both sexes with an increasing incidence. There is an apparent relationship between the development of countries and the epidemiology of cancer; the objective of this article is to observe the epidemiology of bladder cancer in our environment respect to other countries and to describe the possible associated factors. Methods A review of the literature was performed in four databases: Medline, Embase, Cochrane database and Lilacs. Studies about Incidence, prevalence, mortality, survival and burden of disease, published in the past 5 years, were included. Results 7806 references were found that were discriminated by title and abstract, 44 references in full text were included at the end. Different incidence and mortality rates were observed, the highest being found in Europe mainly in the Czech Republic followed by North America. In Colombia, the general incidence was 6.8 / 100,000 in men and 2.1 / 100,000 in women between 2003 and 2007, finding low numbers in departments such as Guajira. Conclusions There has been an increase in the incidence and mortality of bladder cancer worldwide. There seems to be an association with smoking and diet, as well as with the Human Development Index. There is little information in Latin America; in Colombia, observing the data of some departments and the distribution of specialists in the different regions a sub-register can be consider, making necessary to improve surveillance systems, as well as health policies for the diagnosis and early intervention of cancer.

Asunto(s)

RESUMEN

INTRODUCTION: Renal cell carcinoma (RCC) is the ninth most common cancer in men, and the 14th most common cancer in women. It has been reported that the incidence of RCC is rising. These changes are more common in developed countries because of better screening programs and disease registry. The aim of this article is to review the epidemiology of RCC around the world. METHODS: A literature review of four databases was performed: PubMed, Embase, Lilacs, and Scielo. Studies of incidence, prevalence, mortality, and survival of RCC were taken from different countries. Studies included were published in the last 10 years. Two reviewers independently selected the studies. RESULTS: A total of 5275 references were reviewed by title and abstract. In the end, 42 references were selected for full-text review. The global incidence and prevalence of cancer vary. The highest incidence was described in North America and Northern Europe. In Canada, by 2007 the incidence was 17.9/100 000 and 10.3/100 000 in males and females, respectively. Developing countries like Colombia have fewer incidence rates, with less information in poor-income areas. CONCLUSIONS: We have seen a rise in the incidence and mortality of RCC globally. There is an association between RCC and smoking, obesity, hypertension, and socioeconomic status. Seeing the epidemiological data from some regions in developing countries and the lack of specialists in those places, it can be deduced there is underreporting of the disease that reveals the need to improve both surveillance and disease registration programs, especially in these countries.